New insulin pump shows promise for type 2 diabetes control

NCT ID NCT07276776

Completed Disease control Sponsor: Insulet Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable insulin pump system (Omnipod M) in 40 adults aged 18-75 with type 2 diabetes. The goal was to see if the system helps keep blood sugar in a safe range and reduces dangerous highs and lows. Participants used the system for 6 weeks, and researchers measured time spent in low and high blood sugar levels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES MELLITUS

Contacts and locations

Locations

Disease & Glandular Disease Clinic

San Antonio, Texas, 78229, United States
Henry Ford Health

Detroit, Michigan, 48202, United States
Joslin Diabetes

Boston, Massachusetts, 02215, United States
MassResearch LLC.

Waltham, Massachusetts, 02453, United States
Mountain Area Health Educational Center ( MAHEC)

Asheville, North Carolina, 28803, United States
Texas Diabetes and Endocrinology (TDE)

Austin, Texas, 78731, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.